These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 19019772)
1. Percentage of tumor and tumor length in prostate biopsy specimens: a study of American veterans. Vollmer RT Am J Clin Pathol; 2008 Dec; 130(6):940-3. PubMed ID: 19019772 [TBL] [Abstract][Full Text] [Related]
2. Percentage of tumor in prostatectomy specimens: a study of American Veterans. Vollmer RT Am J Clin Pathol; 2009 Jan; 131(1):86-91. PubMed ID: 19095570 [TBL] [Abstract][Full Text] [Related]
4. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB. Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691 [TBL] [Abstract][Full Text] [Related]
5. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia. Zhao Z; Liu J; Li S; Shen W Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463 [TBL] [Abstract][Full Text] [Related]
6. Risk stratification of high-grade prostate cancer treated with antegrade radical prostatectomy with intended wide resection. Yamamoto S; Kawakami S; Yonese J; Fujii Y; Tsukamoto T; Ohkubo Y; Komai Y; Ishikawa Y; Fukui I Jpn J Clin Oncol; 2009 Jun; 39(6):387-93. PubMed ID: 19395463 [TBL] [Abstract][Full Text] [Related]
7. Radical prostatectomy for high-risk prostate cancer: biochemical outcome. Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167 [TBL] [Abstract][Full Text] [Related]
8. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme. Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847 [TBL] [Abstract][Full Text] [Related]
9. Do clinically insignificant tumors of the prostate exist? Stamatiou K; Alevizos A; Mariolis A; Spiliopoulou C; Alevizou A; Bovis K; Sofras F Urol Int; 2008; 81(4):379-82. PubMed ID: 19077395 [TBL] [Abstract][Full Text] [Related]
10. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784 [TBL] [Abstract][Full Text] [Related]
11. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy. Sankin A; Tareen B; Lepor H Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study. Erbersdobler A; Isbarn H; Steiner I; Schlomm T; Chun F; Mirlacher M; Sauter G Urology; 2009 Nov; 74(5):1169-73. PubMed ID: 19476978 [TBL] [Abstract][Full Text] [Related]
13. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy. Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280 [TBL] [Abstract][Full Text] [Related]
14. Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome. Ricciardelli C; Sakko AJ; Stahl J; Tilley WD; Marshall VR; Horsfall DJ Prostate; 2009 May; 69(7):761-9. PubMed ID: 19189303 [TBL] [Abstract][Full Text] [Related]
15. Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancer. Matsuyama H; Oba K; Matsuda K; Yoshihiro S; Tsukamoto M; Kinjo M; Sagiyama K; Takei M; Yamaguchi A; Sasaki K; Naito K Cancer Genet Cytogenet; 2007 Apr; 174(1):24-34. PubMed ID: 17350463 [TBL] [Abstract][Full Text] [Related]
17. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation. Demanes DJ; Brandt D; Schour L; Hill DR Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902 [TBL] [Abstract][Full Text] [Related]
18. Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality. Zelefsky MJ; Shi W; Yamada Y; Kollmeier MA; Cox B; Park J; Seshan VE Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1350-6. PubMed ID: 19515504 [TBL] [Abstract][Full Text] [Related]